Translation and Validation of Chinese COMPAT-SF
Recruiting now
Conditions studied: Chronic Pancreatitis
In brief
The goal of this observational study is to translate, adapt, and test the reliability of a Chinese version of the Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) for people with chronic pancreatitis. The study will answer these questions: * Does the Chinese COMPAT-SF work well to measure pain in people with chronic pancreatitis? * Is the Chinese COMPAT-SF accurate and reliable over time? Participants will: * Complete the Chinese COMPAT-SF questionnaire two times, with a 2-week gap. * Answer additional pain-related questions using the Brief Pain Inventory (BPI) and the Izbicki Pain Score. * Participate in a follow-up to check if the questionnaire gives consistent results over time. This study will help make sure that doctors in China have a useful and reliable tool to measure pain in people with chronic pancreatitis.
Key facts
- Study ID
- NCT06917716
- Run by
- Changhai Hospital
- People needed
- 356
- Starts
- 2025-03-10
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-04-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 1. Diagnosed with chronic pancreatitis (CP) according to the Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis in China (2018 edition). Diagnosis can be confirmed by: •Primary diagnostic criteria: (i) Definitive imaging findings, and (ii) Histopathological confirmation. •Secondary diagnostic criteria: (i) Recurrent upper abdominal pain, (ii) Abnormal serum amylase levels, (iii) Pancreatic exocrine insufficiency, (iv) Pancreatic endocrine insufficiency, (v) Pathogenic gene mutations, and (vi) History of heavy alcohol consumption. •Diagnosis is confirmed if at least one primary criterion or two secondary criteria are met.
- 2. Experience of pancreatic pain in the past 12 months
You may not qualify if…
- Under 18 years of age.
- No pancreatic-related pain.
- Diagnosed with pancreatic cancer or other tumors.
- Presence of communication or reading impairments.
- Refusal to participate in the study.
Where it is running
- Changhai Hospital — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.